Clinical Trial Update: Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma [Phase 3]

View source ↗

Summary

This Phase 3 trial comparing paclitaxel vs doxorubicin in advanced AIDS-related Kaposi sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Kaposi Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: AIDS-related Kaposi Sarcoma | Phase 3 | Status: COMPLETED